Seller record · Telehealth service
NuviaRx
Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the GLP-1 page, the answers or the policies.
At a glance
NuviaRxTelehealth service
- Price
- Semaglutide from $140 a month and tirzepatide from $170 a month on an annual plan
- Sells
- compounded semaglutide, compounded tirzepatide
- FDA letters
- None on file
Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.
A telehealth weight loss service selling compounded semaglutide and tirzepatide at one price for every dose, with the lowest monthly price tied to an annual plan. Care starts with an online medical questionnaire reviewed by a licensed doctor, and its answers name two filling pharmacies with street addresses.
Operating entity NuviaRx Health Inc.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | NuviaRx's FAQ; NuviaRx's how it works page |
| S2 | Prescription gating | PASS | NuviaRx's FAQ; NuviaRx's how it works page |
| S3 | Pharmacy identification | PASS | NuviaRx's FAQ |
| S4 | Compounding disclosure | PASS | NuviaRx's GLP-1 page |
| S5 | Analytical documentation | FAIL | NuviaRx's GLP-1 page; NuviaRx's FAQ; NuviaRx's terms |
| S6 | Business address | PASS | NuviaRx's terms; NuviaRx's website |
| S7 | Price disclosure | PASS | NuviaRx's GLP-1 page; NuviaRx's medications page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.